Legis Daily

Stop COVID–19 Test Surprise Medical Bills Act of 2021

USA117th CongressHR-533| House 
| Updated: 2/2/2021
Lizzie Fletcher

Lizzie Fletcher

Democratic Representative

Texas

Cosponsors (19)
Al Lawson (Democratic)Kim Schrier (Democratic)Sylvia R. Garcia (Democratic)Raúl M. Grijalva (Democratic)Sheila Jackson Lee (Democratic)Mondaire Jones (Democratic)Daniel T. Kildee (Democratic)Henry C. "Hank" Johnson (Democratic)Jahana Hayes (Democratic)Mark Takano (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Nydia M. Velázquez (Democratic)Alcee L. Hastings (Democratic)Veronica Escobar (Democratic)Lauren Underwood (Democratic)Katie Porter (Democratic)Mike Levin (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Stop COVID-19 Test Surprise Medical Bills Act of 2021 This bill modifies provisions requiring health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) diagnostic testing services at no cost, without prior authorization, and without medical management requirements. The bill specifies that a plan may not make determinations about the circumstances surrounding individuals' tests, such as why they sought testing or whether they showed symptoms of COVID-19. The bill also specifies that plans may encourage individuals to obtain tests from lower priced providers as long as such efforts do not delay, or impede access to, testing. The bill also requires the Department of Health and Human Services (HHS) to survey and report on the cash prices of testing services and the compliance of providers with the requirement to publish such prices. Additionally, HHS, jointly with the Department of the Treasury and the Department of Labor, must issue guidance clarifying the process for submitting claims for testing services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-8419
Stop COVID–19 Test Surprise Medical Bills Act of 2020
Jan 28, 2021
Introduced in House
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 28, 2021
Referred to the Subcommittee on Health.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jul 21, 2021

Latest Companion Bill Action

S 117-2411
Introduced in Senate
  • Bill from Previous Congress

    HR 116-8419
    Stop COVID–19 Test Surprise Medical Bills Act of 2020


  • January 28, 2021
    Introduced in House


  • January 28, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • January 28, 2021
    Referred to the Subcommittee on Health.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • July 21, 2021

    Latest Companion Bill Action

    S 117-2411
    Introduced in Senate

Health

Related Bills

  • S 117-2411: Stop COVID–19 Test Surprise Medical Bills Act of 2021
Cardiovascular and respiratory healthEmergency medical services and trauma careEmployee benefits and pensionsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessInfectious and parasitic diseasesMedical tests and diagnostic methodsMedicare

Stop COVID–19 Test Surprise Medical Bills Act of 2021

USA117th CongressHR-533| House 
| Updated: 2/2/2021
Stop COVID-19 Test Surprise Medical Bills Act of 2021 This bill modifies provisions requiring health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) diagnostic testing services at no cost, without prior authorization, and without medical management requirements. The bill specifies that a plan may not make determinations about the circumstances surrounding individuals' tests, such as why they sought testing or whether they showed symptoms of COVID-19. The bill also specifies that plans may encourage individuals to obtain tests from lower priced providers as long as such efforts do not delay, or impede access to, testing. The bill also requires the Department of Health and Human Services (HHS) to survey and report on the cash prices of testing services and the compliance of providers with the requirement to publish such prices. Additionally, HHS, jointly with the Department of the Treasury and the Department of Labor, must issue guidance clarifying the process for submitting claims for testing services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-8419
Stop COVID–19 Test Surprise Medical Bills Act of 2020
Jan 28, 2021
Introduced in House
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 28, 2021
Referred to the Subcommittee on Health.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jul 21, 2021

Latest Companion Bill Action

S 117-2411
Introduced in Senate
  • Bill from Previous Congress

    HR 116-8419
    Stop COVID–19 Test Surprise Medical Bills Act of 2020


  • January 28, 2021
    Introduced in House


  • January 28, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • January 28, 2021
    Referred to the Subcommittee on Health.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • July 21, 2021

    Latest Companion Bill Action

    S 117-2411
    Introduced in Senate
Lizzie Fletcher

Lizzie Fletcher

Democratic Representative

Texas

Cosponsors (19)
Al Lawson (Democratic)Kim Schrier (Democratic)Sylvia R. Garcia (Democratic)Raúl M. Grijalva (Democratic)Sheila Jackson Lee (Democratic)Mondaire Jones (Democratic)Daniel T. Kildee (Democratic)Henry C. "Hank" Johnson (Democratic)Jahana Hayes (Democratic)Mark Takano (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Nydia M. Velázquez (Democratic)Alcee L. Hastings (Democratic)Veronica Escobar (Democratic)Lauren Underwood (Democratic)Katie Porter (Democratic)Mike Levin (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

Health

Related Bills

  • S 117-2411: Stop COVID–19 Test Surprise Medical Bills Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthEmergency medical services and trauma careEmployee benefits and pensionsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessInfectious and parasitic diseasesMedical tests and diagnostic methodsMedicare